ELEVATION PHARMACEUTICALS
Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. There founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients' lives. At Elevation, they have a disciplined approach to strategic decision-making that helps us stay focused on the path with the highest probability of success. They are executing our drug development plans with passion, integrity, and a high sense of urgency in order to meet the needs and expectations of our stakeholders -- employees, investors, partners, and patients.
ELEVATION PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2007-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.elevationpharma.com
Total Employee:
11+
Status:
Active
Contact:
858-436-1616
Email Addresses:
[email protected]
Total Funding:
89.4 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon IPv6 Microsoft Azure DNS DMARC Amazon CloudFront Dmarcian
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Salient Pharmaceuticals
Salient is developing CASAD™, a proprietary composition proven to adsorb a range of toxins and inflammatory proteins.
Current Employees Featured
Founder
Investors List
Canaan Partners
Canaan Partners investment in Series B - Elevation Pharmaceuticals
Care Capital
Care Capital investment in Series B - Elevation Pharmaceuticals
Novo Ventures
Novo Ventures investment in Series B - Elevation Pharmaceuticals
TPG Biotech
TPG Biotech investment in Series B - Elevation Pharmaceuticals
Mesa Verde Venture Partners
Mesa Verde Venture Partners investment in Series B - Elevation Pharmaceuticals
TPG Growth
TPG Growth investment in Series A - Elevation Pharmaceuticals
Canaan Partners
Canaan Partners investment in Series A - Elevation Pharmaceuticals
Care Capital
Care Capital investment in Series A - Elevation Pharmaceuticals
Mesa Verde Venture Partners
Mesa Verde Venture Partners investment in Series A - Elevation Pharmaceuticals
TPG Growth
TPG Growth investment in Series A - Elevation Pharmaceuticals
Official Site Inspections
http://www.elevationpharma.com
Unable to get host informations!!!
More informations about "Elevation Pharmaceuticals"
Levation Pharma, Ltd
About Levation. Levation Pharma, Ltd. is an Israeli-American company that was founded on the basis of intellectual property licensed from its Founders and relating to the treatment of Acquired Blepharoptosis.See details»
Levation Pharma - Crunchbase Company Profile & Funding
When was the last funding round for Levation Pharma? Levation Pharma closed its last funding round on Mar 31, 2020 from a Venture - Series Unknown round. Who are Levation Pharma 's …See details»
Levation pharma LTD - Company Profile and News
Company profile page for Levation pharma LTD including stock price, company news, executives, board members, and contact informationSee details»
LEVATION PHARMA LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for LEVATION PHARMA LTD of TEL AVIV-JAFFA, Central District. Get the latest business insights from Dun …See details»
Levation Pharma Ltd. - Drug pipelines, Patents, Clinical trials
It is venture backed by prominent venture firms Pontifax and Peregrine amongst other investors. For further information see our website at . LEV102 in an Investigational New Drug and is not …See details»
Levation Pharma - Products, Competitors, Financials, Employees ...
Levationpharma.com. Overview & Products; Financials; People; Founded Year 2017. Stage Other Investors | Alive. About Levation Pharma. Levation Pharma focuses on the development of …See details»
Levation Pharma, Ltd. | LinkedIn
Levation Pharma, Ltd. Pharmaceutical Manufacturing A clinical stage pharmaceutical company developing new treatments for aesthetic and functional eyelid conditions.See details»
Levation Pharma - Company Profile - Tracxn
Oct 20, 2024 Levation Pharma ranks 3rd among 3 active competitors. 1 of its competitors is exited. Overall, Levation Pharma and its competitors have raised over $60M in funding across …See details»
Levation Pharma Ltd. (Levation Pharma Ltd.) - 药物管线_专利_临床 …
It is venture backed by prominent venture firms Pontifax and Peregrine amongst other investors. For further information see our website at . LEV102 in an Investigational New Drug and is not …See details»
Levation Pharma - Overview, News & Similar companies - ZoomInfo
Popular Searches Levation Pharma Ltd Levationpharma.com SIC Code 28,283 NAICS Code 32,325 Show more. View Email Formats for Levation Pharma. Top Companies in United …See details»
Levation Pharma - PitchBook
Levation Pharma General Information Description. Developer of a topical oxymetazoline product designed to be used for cosmetic eye lifts. The company offers a drying aqueous gel …See details»
Levation Pharma - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 31, 2020: Venture Round - …See details»
Elevation Pharmaceuticals - Crunchbase Company Profile & Funding
Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. There founding team has a successful track record starting …See details»
Levation Pharma Initiates Phase I/II Clinical Trial of LEV102 for ...
Feb 27, 2023 Double Masked, Placebo Control Study at Three Prominent U.S. Sites /EIN News/ -- LOS ANGELES, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Levation Pharma Ltd., a …See details»
Elevation Pharmaceuticals - Ownership and Business Overview
Sep 5, 2012 Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012.The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was …See details»
Elevation Pharmaceuticals - Crustdata Company Profile, Funding …
Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. There founding team has a successful track record starting …See details»
Levation Pharma Initiates Phase I/II Clinical Trial of ... - BioSpace
LOS ANGELES, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Levation Pharma Ltd., a pharmaceutical company focused on the development of new therapeutics for the ophthalmology and …See details»
Levation Pharma Initiates Phase I/II Clinical Trial of LEV102 for ...
Feb 27, 2023 Double Masked, Placebo Control Study at Three Prominent U.S. SitesLOS ANGELES, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Levation Pharma Ltd., a pharmaceutical …See details»
Levation Pharma Initiates Phase I/II Clinical Trial of - GlobeNewswire
Feb 27, 2023 For further information see our website at www.levationpharma.com. LEV102 in an Investigational New Drug and is not approved for any indications. For further information see …See details»
Elevation Pharmaceuticals - Company Profile - Tracxn
Nov 27, 2024 What are the most recent funding rounds of Elevation Pharmaceuticals? Its latest funding round was a Series B round on Jan 04, 2012 for $30M. 5 investors participated in its …See details»